chr1-171275479-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001282693.2(FMO1):āc.455A>Gā(p.Asn152Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,612,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001282693.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO1 | NM_001282693.2 | c.455A>G | p.Asn152Ser | missense_variant | 4/9 | ENST00000617670.6 | NP_001269622.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO1 | ENST00000617670.6 | c.455A>G | p.Asn152Ser | missense_variant | 4/9 | 1 | NM_001282693.2 | ENSP00000481732.1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151902Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249576Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134862
GnomAD4 exome AF: 0.000129 AC: 189AN: 1460152Hom.: 0 Cov.: 30 AF XY: 0.000118 AC XY: 86AN XY: 726328
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151902Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74172
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.455A>G (p.N152S) alteration is located in exon 4 (coding exon 3) of the FMO1 gene. This alteration results from a A to G substitution at nucleotide position 455, causing the asparagine (N) at amino acid position 152 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at